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Abstract 
Background: The risk of heart diseases, diabetes and stroke is increased with higher metabolic risk factors. Models of 
diseases resulting from high-calorie diets have a significant role in pathophysiologic analysis of metabolic syndrome 
in rodents; but, these diets are considerably different from each other in various studies and may not be very similar 
to the metabolic syndrome model in humans. This study sought to make a model close to the disease in humans. 
20 five-week old male Wistar rats were randomly assigned to two groups. For one of the groups, a high-calorie diet 
with 416 calories per 100 g with dairy-based fat was considered and, for another group, a control diet was given for 
12 weeks. Weight changes, lipid profile, glucose values, Blood pressure, insulin and HOMA indices, were measured 
for both groups and weight changes were compared using repeated measures and independent t test; also, serum 
results were compared using independent t test.
Results: Values of weight, glucose, insulin, lipid profile and blood pressure, except HDL, had a tangible difference 
between two groups at the end of the study. HOMA-IR, HOMA-B and HOMA-S indicates a significant difference 
between the two groups after consumption high-energy diet.
Conclusion: The present study showed ability of dairy fat in gaining weight, insulin resistance and metabolic syn-
drome and provided the necessity of paying serious attention to the amount of fat intake from dairy sources.
Keywords: Metabolic syndrome, Diet, High-calorie diet, High-fat diet, Wistar rat, HOMA-IR, Insulin
© The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
A brief look at human societies shows that most of us 
are overweight and it is becoming an epidemic in devel-
oped societies. Obesity can be the source of diseases like 
insulin resistance, abnormal levels of blood fat (high tri-
glyceride and low high-density lipoproteins) and hyper-
tension. The term metabolic syndrome (MS) is used to 
describe simultaneous occurrence of these diseases and 
people suffering from metabolic syndrome are at higher 
risk of cardiovascular diseases, type 2 diabetes, cancer 
and non-alcoholic fatty liver (Panchal et al. 2011; Ghaemi 
et  al. 2013). According to the report of National Health 
and Nutrition Examination Survey (2003–2006), preva-
lence rate of metabolic syndrome in American society 
was still increasing by about 34% (Ford et  al. 2010). It 
has been estimated that, in the United States, every indi-
vidual with metabolic syndrome spends about 4000$ for 
treatment per year.
The underlying cause of metabolic syndrome is 
unknown although insulin resistance and visceral fat 
accumulation have been identified as its backgrounds 
(Alberti et al. 2009; Babai et al. 2016). Insulin resistance 
(IR) is a physiological condition in which insulin hor-
mone finds less ability in reducing blood sugar. The sub-
sequent increase of blood sugar can be so high that may 
exceed normal range of blood sugar and cause health 
problems. Certain cell species such as fat and muscle 
cells require insulin for entry of glucose inside the cell. 
If these cells do not respond to the insulin circulating 
in blood flow, blood sugar increases. Insulin resistance 
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leaves various effects which include reduced ability of fat 
cells in removing blood lipids and increased hydrolysis of 
environmental triglycerides. This hydrolysis leads to the 
increased number of free fatty acids in blood flow and its 
subsequent health problems (Abranches et al. 2015).
Similar to many diseases, risk of metabolic syndrome is 
also the result of interaction between genes and the sur-
rounding environment (Tsai and Schumann 2015). Since 
human genotypes have not been changed during several 
centuries, therefore, environmental factors should be 
considered the main factor of increasing suffering from 
metabolic syndrome in recent years (Panizzon et al. 2015). 
One of the major issues in this regard is energy balance 
which is established between energy intake through food 
and consumed rate of energy during physical activities. In 
addition to energy balance, types of food are also impor-
tant. From the evolutionary perspective, it has been stated 
that obesity and other relevant diseases are in fact the nat-
ural result of high calorie intake (Frankenfeld et al. 2015). 
During evolution, since food sources were not constant 
and starvation periods were common, having genes which 
allowed for efficient storage of calorie in the form of fat 
was an advantage. In today’s societies, the problem is that 
we still have these economic genes although we are sur-
rounded by foods rich in saturated fats, simple sugars and 
salt. On the other hand, there is this reality that long-term 
limitation of energy consumption causes increased lon-
gevity (López‐Lluch and Navas 2015).
Treatment costs of metabolic syndrome is increasing 
and there is no surprise that medical society is seeking 
animal models which simulate this disease in humans in 
order to test effects of certain foods on pathogenesis and/
or potential human treatments on them. Owing to the 
axial role of diet in inducing this failure in humans, most 
of disease models in animals use a diet for inducing these 
conditions.
Animal models are systems that are made in order to 
create examinable conditions in other species and they 
can be almost divided into two categories of natural and 
genetic models (van der Staay 2006). Today, animals are 
widely used by genetic manipulation for the studies rele-
vant to diabetes. These animals show high hyperinsuline-
mia that are not observed in human samples with type 
2 diabetes despite its usefulness for studies. Moreover, 
such a genotype is not observed in humans. In contrast, 
the diet-induced model of diabetes caused by high-
caloric diet obesity is more similar the type 2 diabetes 
model in humans, which is usually the result of obesity 
and overweight. Obese animals by diet generally have a 
mild increase in serum insulin level than control animals 
whereas their glucose level is either increased or constant 
(Srinivasan and Ramarao 2007; Homayounfar et al. 2015).
In this study, it was attempted to observe fat effect with 
diary source on capability of disease induction in addi-
tion to trying to generate the closest model of metabolic 
syndrome to the disease existing in the society in terms 
of percentage of macronutrients and energy rate.
Methods
The protocol of the research was approved by both the 
Ethics Committee and the Institutional Review Board of 
Fasa University of Medical Sciences and was in accord-
ance with the animal studies code (1175/1000).
20 five-week old Wistar rats were selected and ran-
domly assigned to two groups. At the beginning of the 
study, weight was not significantly different in both 
groups (68.12  ±  4.58 vs. 72  ±  6.32, P value  =  0.166). 
For one week, a standard diet was given to both groups 
in order to adapt them to the experimental conditions. 
At the end of the first week, one of the groups started 
high-calorie diet with fat from dairy sources (made by 
the researcher) and a control diet was given to another 
group. Food was presented ad  libitum. The animals’ 
environment had temperature of 20–24  °C, 20–70% 
humidity and light and precise darkness cycle of 12  h. 
Ethical points related to animals’ maintenance and the 
conducted experiments in them were based on the pro-
tocol approved by animal protection organizations and 
university. Serum indexes were measured at the end of 
the study and animals’ weight was assessed in one week 
intervals using a scale made by Kentscientific Company 
with accuracy of 0.01 g.
At the end of the twelfth week, after anesthesia using 
ether (which has the least impact on metabolic indica-
tors), blood was taken from the heart and animals’ serum 
was separated. In order to reduce chance of bias in the 
experiments, blood samples were coded. Lipid profile and 
serum insulin were measured in enzymatic manner and 
using kit of Kaimen Company in Elisa method, respec-
tively. Blood pressure were determined in conscious rats 
from two groups by an indirect tail-cuff method (Indirect 
blood pressure meter BP-98A, Softron™, Tokyo, Japan).
Another applied index was HOMA indices (homeo-
static model assessment) which consists of three compo-
nents and shows insulin resistance (HOMA-IR), beta cell 
function percent (HOMA-B) and insulin sensitivity per-
cent (HOMA-S) that calculated by HOMA-2 calculator 
(www.dtu.ox.ac.uk/homacalculator/).
SPSS software was used for the data analysis. In 
order to estimate conformity of data to normal dis-
tribution, Shapiro–Wilk test was used. Weight values 
were analyzed using repeated measures and independ-
ent t-test and comparing mean of serum indexes was 
done by independent t-test. The data were reported as 
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mean ± standard deviation and P < 0.05 was considered 
significant (Tables 1, 2).
Results
At the end of the twelfth week, the results were as follows. 
In Fig.  1, weight increase trend of both groups can be 
observed. The remarkable point in becoming almost flat 
curve of the control group since around the seventh week 
of starting diet which coincided with their twelfth week 
growth; it seems that this point was due to their maturity 
and stop of body growth whereas weight increase contin-
ued in the group taking the high-calorie diet.
Values of serum indexes including insulin, glucose, lipid 
profile and blood pressure in the group consuming high-
calorie diet showed significant difference from the group 
consuming control diet. In fact, the difference of both 
groups was not significant in terms of HDL (Table 3).
Discussion
In this study, metabolic syndrome and insulin resist-
ance were managed to be induced in normal rats (with-
out genetic change) via dieting. As mentioned in the 
introduction, the term metabolic syndrome (MS) is used 
for describing simultaneous occurrence of conditions 
such as insulin resistance, abnormal level of blood fats 
(high triglyceride and low high-density lipoproteins) and 
hypertension and people suffering from metabolic syn-
drome are at higher risk of cardiovascular diseases, type 2 
diabetes, cancer and non-alcoholic fatty liver. Considering 
growing trend of this disease, the importance of studying 
such circumstances is highlighted and, since this disease 
is more associated with pattern and life style of people 
and their tendency to use western diets, studies which 
can simulate such conditions and have not been made by 
pharmaceutical or genetic interventions will have more 
proximity to the society’s existing conditions; having 
such a model can provide the way for more studies to find 
cause and treatment mechanisms of these patients. Cur-
rently, genetic models of this disease are available, which 
have both high price and (as mentioned earlier) low gen-
eralizability to ordinary patients of the society because 
this disease is not normally caused by genetic defects or 
single nucleotide polymorphisms and is simply the result 
of incorrect life style, high energy consumption and inac-
tivity. The diet which was used in this study contained 
45% energy from carbohydrates, 41% from fat and 14% 
from protein, which was highly similar to high-energy 
diet used by the society. Most of commercially available 
diets provide 60% of fat, which is not much similar to the 
common diet of people due to effectiveness in obesity and 
inducing insulin resistance and lipid profile disorder; this 
issue undermines their generalizability to the population 
and research results. Studies have suggested that such ani-
mal models have similar characteristics to humans and 
they can be used for simulating human studies (Srinivasan 
and Ramarao 2007).
Values of diet compounds do not have a specific defini-
tion. Typically, low-fat diets contain 10% calorie from fat, 
high-fat diets have 30–50% energy from fat source and 
very high-fat diets have more than 50% energy. To induce 
obesity, both high-fat and very high-fat diets are used 
and body weight depends on the amount of fat (Ghibaudi 
et al. 2002).
Source of the used fat is also important. Some research-
ers have reported that different fats induce various pho-
notypes (Hariri and Thibault 2010). For instance, for 
rodents with equal diets in terms of fat, the ones which 
received fish oil gained less weight and had higher insu-
lin sensitivity than those who had a diet rich in saturated 
fat (Buettner et al. 2006; Wang et al. 2002). However, all 
articles have not reported such results and suggest effec-
tiveness of fat value and gender (Ikemoto et al. 1996; Pel-
lizzon et al. 2002).
Rodents have more tendency to gain weight on high-
fat or very high-fat diets. However, in glucose tolerance, 
Table 1 Composition of high fat diet and control diet













47 45 187 58 175
Fat 19 41 171 13 39
Protein 14.5 14 58 28 84
Total 100 416 100 302
Table 2 Fatty acid composition of 100 g of diet
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insulin resistance, triglyceride levels and other factors, 
dependence on gender and species (Rossmeisl et al. 2003) 
and dietary fat sources (Buettner et  al. 2006; Ikemoto 
et  al. 1996; Wang et  al. 2002) are also effective. Studies 
have shown that Wistar and Sprague–Dawley rats are 
divided into two categories of obesity resistant and get-
ting obese with diet in terms of their response to high-fat 
diet. For the researchers interested in the field of obesity 
and type 2 diabetes, male ZDF rats are available which 
become obese and diabetic even by consuming low-fat 
diet; high-fat diet causes more serious diseases in them. 
Its females do not suffer from diabetes in spite of gain-
ing weight unless they receive a diet containing 48% fat 
energy (Srinivasan et al. 2005). Insulin resistance induced 
before development of diabetes in these rats (especially, 
females) enable researchers to study their pre-diabetic 
condition (Baxter et al. 2006).
Various species of rats show different behaviors against 
high-fat diets (more than 60% energy from fat). Cer-
tain mice like C57BL/6 or AKR are sensitive to obesity 
by such diets (Rossmeisl et al. 2003); but, others such as 
A/J and SWR/J are resistant to obesity (Hata et al. 1996; 
Pereira et al. 2002). Hence, this study tried to use high-fat, 
not very high-fat, diets for inducing obesity and insulin 
resistance; additionally, generalizability to the society was 
attempted to be higher using this model because there 
are few people with energy intake of above 50%.
The first description of high-calorie diet for making 
obesity model dates back to 1959 (Thomas and Hartroft 
1959). Its subsequent studies have demonstrated that 
high-fat diets cause hyperglycemia and insulin resist-
ance (Assaad et al. 2014; Pound et al. 2014). Studies have 
also indicated that high consumption of saturated fat 
acids and cholesterol leads to increased blood choles-
terol and LDL (Pound et al. 2014) and increased risk of 
heart diseases. Similar to humans, high-fat diet (with a 
large amount of saturated acids) and cholesterol (approx-
imately about 0.2 weight percent), which is known as 
western diet, can cause increase in total cholesterol and 
LDL-C in rats.
Buettner et al. (2006) gave four types of high-fat diets 
with 42% energy from fat to rats which included lard, 
olive, coconut and fish oil in order to compare effects of 
various high-fat diets on metabolic processes of rats; after 
12  weeks, certain indexes such as weight, insulin toler-
ance, lipid profile, serum glucose and insulin resistance 
Fig. 1 Diagram of weight changes in gram in both groups of high-calorie and control diets in 12 weeks
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index were measured. Their reports showed that maxi-
mum gain weight occurred in the group consuming high-
fat diet with lard source, which had weight difference 
of about 100 g from the control group at the end of the 
study (504 ±  36 vs. 606 ±  54, P value  <0.05). This sig-
nificant difference in weight was also established for the 
groups consuming high-fat diet with olive oil and coco-
nut oil sources; however, they demonstrated lower values 
of weight difference. In contrast, the group taking high-
fat diet with fish oil source had a similar final weight to 
the control group. Except the group consuming high-fat 
with olive oil source, glucose values did not have any sig-
nificant difference from the control group (5.6 ± 0.3 vs. 
5.0 ± 0.3, P value <0.05). As far as insulin was concerned, 
there was a significant difference between the group con-
suming high-fat diet with lard source and the control 
(780 ± 230 vs. 577 ± 223, P value <0.05). Insulin resist-
ance index in the group consuming lard fat had evident 
difference from the control group (27.2 ± 8 vs. 19 ± 8.5, 
P value <0.05).
In the study by Ghibaudi et al. (Ghibaudi et al. 2002), 
three diets with fat of 10, 32 and 45% energy from vari-
ous sources were compared with each other. Based on 
the findings, high-fat diet (45% energy from fat) caused 
more increase of total body weight in addition to more 
increase in body fat percent compared with groups with 
medium (32%) and low (10%) fat intake (33.64% ±  1.76 
vs. 28.28% ± 1.79 and 20.75% ± 2.88; P value <0.05) As 
the same time, it increased glucose level, cholesterol, free 
fatty acids, triglyceride and serum leptin compared with 
the mentioned groups; but, the difference of serum insu-
lin was not significant.
In the study by Rossmeisl et al. (2003), difference of two 
low-fat (12% energy from fat) and high-fat (58% energy 
from fat) diets was investigated in two types of AKR and 
B6 rats. According to their reports, both groups of rats 
did not have any significant weight difference in both 
diets (low-fat and high-fat) although BS rats gained more 
weight increase than AKR rats. However, results were 
significantly different for blood glucose, insulin, triglycer-
ide and serum free fatty acids. The study concluded that 
fat B6 rats had more glucose tolerance at the end of the 
study whereas fat AKR rats had more insulin resistance. 
They reported that fat tissue of B6 rats was three time 
higher than that of AKR rats which had GLUT4 whereas 
expression of this receptor in adipose tissue was similar 
in both rats. Thus, in addition to type of diet, it is pos-
sible to mention that class and species of animals are also 
determining for emergence of diseases resulting from 
food.
Pagliassotti et  al. (2000) conducted a work in which 
three diets with similar calories of 68% energy from 
starch, 45% fat or 68% sucrose were used in four age 
groups of 5 (weaned), 10 (young), 18 (mature) and 58 
(old) weeks old. The results showed that there was rela-
tive insulin resistance resulting from the process of aging 
in the comparison of groups, either at the beginning or 
at the end of the study; but, diet was also influential. The 
interesting point shown in the study was inability of diet 
with high sucrose in inducing insulin resistance in the 
weaned rats. Accordingly, the study focused on both pro-
cesses of aging and diet leading to an increase in mass of 
body fat as a major factor for inducing insulin resistance.
To the best of the authors’ knowledge, this is the only 
study that has used fat from diary origin for induc-
ing obesity and obesity related complications such as 
metabolic syndrome, hypertention and dyslipidemia. 
Table 3 Serum biomarkers at the end of study
a Significant difference compared to control group P value <0.05
b Significant difference compared to control group P value <0.001
c Significant difference compared to baseline P value <0.05
d Significant difference compared to baseline P value <0.001
Before After Differences
Insulin (ng/ml)
 High fat diet 1.97 ± 0.62 4.49 ± 1.29b,d 2.51 ± 1.26b
 Control diet 1.70 ± 0.59 2.15 ± 0.46 0.44 ± 0.67
Cholesterol (mg/dl)
 High fat diet 41.74 ± 4.86 60.70 ± 6.88b,d 18.95 ± 7.27b
 Control diet 40.85 ± 4.17 46.60 ± 7.82 5.75 ± 8.55
Glucose (mg/dl)
 High fat diet 145.72 ± 17.62 183.60 ± 34.90a,c 37.87 ± 47.54a
 Control diet 135.27 ± 17.76 152.40 ± 15.48 17.12 ± 29.85
HDL (mg/dl)
 High fat diet 22.75 ± 7.91 34.70 ± 8.42c 11.94 ± 15.16
 Control diet 23.27 ± 7.74 31.80 ± 10.88 8.52 ± 12.80
TG (mg/dl)
 High fat diet 53.50 ± 12.89 124.60 ± 46.43b,d 71.09 ± 53.84b
 Control diet 62.43 ± 14.21 57.20 ± 24.02 −5.23 ± 28.71
Systolic BP (mmHg)
 High fat diet 128.08 ± 13.89 147.43 ± 20.84a,c 19.35 ± 23.89a
 Control diet 127.21 ± 13.00 123.58 ± 16.02 −3.62 ± 23.20
Diastolic BP (mmHg)
 High fat diet 85.69 ± 8.35 94.97 ± 3.77a,c 9.28 ± 9.41a
 Control diet 88.44 ± 3.98 86.86 ± 4.33 −1.57 ± 4.96
HOMA-IR
 High fat diet 0.63 ± 0.21 1.52 ± 0.24b,d 0.89 ± 0.21b
 Control diet 0.65 ± 0.20 0.68 ± 0.23 0.03 ± 0.25
HOMA-B %
 High fat diet 61.27 ± 22.50 92.68 ± 18.10a,d 31.40 ± 29.66b
 Control diet 60.79 ± 19.90 64.84 ± 24.73 4.04 ± 41.32
HOMA-S %
 High fat diet 67.55 ± 30.25 52.39 ± 18.97a 15.15 ± 34.53b
 Control diet 72.39 ± 23.66 69.48 ± 17.00 2.90 ± 33.96
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Although lard was not used in the present study as a fat 
source (which, according to most studies, is a major fac-
tor for increasing blood cholesterol and inducing insulin 
resistance) and animal fat with dairy source was applied, 
a significant increase was found in levels of glucose, insu-
lin, cholesterol, triglyceride and also insulin resistance. In 
fact, no study which has used such type of fat for weight 
gain or insulin resistance has been found; accordingly, 
it can be concluded that animal fat with diary sources 
is capable of increasing fat and obesity as much as lard 
fat and can be used to substitute such fat in studies; also, 
such type of fat should be considered with more accu-
racy in dietary analyses. The importance of using fat from 
non-lard source in this study, is in its interoperability to 
Muslim cultures that religious beliefs do not permit them 
to use the products of pig origin. So the conventional 
models of diet-induced obesity, that uses Lard, could not 
generalize to these communities.
Numerous studies have indicated the ability of dairy 
fat in decreasing risk of chronic diseases, especially 
metabolic syndrome (Azadbakht et al. 2005; Baxter et al. 
2006). CARDIA’s study showed that the diet pattern dif-
ferentiated by frequent consumption of dairy products 
is able to reduce most risk factors of chronic diseases 
such as overweight (Pereira et  al. 2002), hypertension 
(Hata et al. 1996) and hypercholesterolemia (Buonopane 
et  al. 1992). On the other hand, there are certain stud-
ies showing that cholesterol and risk of chronic diseases 
may increase by consuming dairies (Lawlor et  al. 2005). 
A point which has been neglected is fat resulting from 
dairy products; these studies have not paid attention 
to the amount of fat resulting from dairy products and 
have been epidemiologic studies for assessing total level 
of diary consumption. These positive effects might be 
attributed to the protein existing in dairy products or its 
resulting calcium. As demonstrated by the present study, 
if net effect of dairy fat was considered without other 
nutrients, ability of gain weight and insulin resistance 
would be evident.
Our results at first glance seem to be at odds with the 
results of studies that suggest a negative relationship 
between dairy consumption and risk of metabolic syn-
drome. There are even studies that have reported con-
suming high-fat dairy foods may decrease the risk of 
developing metabolic syndrome more than low-fat dairy. 
As an example Drehmer and colleagues (Drehmer et al. 
2016) in the Brazilian population cohort (ELSA-Brazil) 
with a population of about 10,000 people concluded that 
the consumption of high-fat dairy products decreased 
metabolic syndrome score (−0.126  ±  0.03, P  <  0.001) 
while low-fat dairy products showed no association. Kim 
and Je in a meta-analysis study (Kim and Je 2015) which 
included nine cohort study with a population of 35,379 
people and 12 cross-sectional study with a population 
of 37,706 people showed that relative risk for develop-
ing the metabolic syndrome in those with the highest 
intake of dairy products compared to the group with the 
lowest intake of dairy in cohort studies was 0.85 (95% 
CI 0.73–0.98) and in cross-sectional studies was 0.73 
(95% CI 0.63–0.86). Such results show a negative cor-
relation between dairy consumption and the prevalence 
of metabolic syndrome. Chen et  al. in a meta-analysis 
study (Chen et  al. 2015) examined 15 cross-sectional 
study, a case–control study and seven cohort study and 
the results showed that higher intake of dairy products 
reduces the risk of metabolic syndrome by as much as 
17% in cross-sectional studies and approximately 14% in 
cohort studies.
The point in comparing our results to these studies 
should be considered is in the components of the diet. 
Mentioned studies (Chen et al. 2015; Drehmer et al. 2016; 
Kim and Je 2015) indicate less chance of developing met-
abolic syndrome by consuming more dairy products in a 
normal diet while the results of our study pays to high-fat 
and high-energy diets impact that its energy comes from 
dairy fat origin. In Drehmer’s study (Drehmer et al. 2016) 
dietary fat intake was up 30% while the amount of fat in 
the diet used in our study was more than 40%. So char-
acteristic of our study is the use of high-energy diet that 
origin of this added energy is from diary fat. While men-
tioned studies have focused more on normal consump-
tion of dairy on a normal diet so perhaps compare our 
study results with them do not correct. Finally, our study 
was not seeking to limit the intake of dairy products in 
the community; rather, it was the investigative work to 
explore the possibility of creating a model of metabolic 
syndrome using a type of fat available in our society.
The relationship of fat intake from dairy with increas-
ing insulin level, glucose and lipid profile suggests patho-
genesis and risk of such types of fats. This fat which has 
its particular fans in the society and sometimes certain 
benefits are mentioned for it exposes the person to the 
risk of disturbing lipid balance and insulin resistance. In 
fact, these results can result from obesity or directly from 
consumption of such fats. In complimentary analysis, by 
adjusting for weight changes, difference of insulin values 
and glucose was not significant between the two groups, 
which indicated that effect of diet on insulin and glu-
cose values was indirectly due to the capability of weight 
increase.
The HOMA values in Table 3 shows a significant insu-
lin resistance by consuming a high calorie diet with dairy 
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fat that emphasize on ability of dairy fat in induction of 
metabolic syndrome.
 In the present study, in spite of less weight increase 
in the group consuming high-fat diet compared to simi-
lar studies, results of glucose, insulin and lipid profile 
had considerable difference between the two groups and 
could be compared with results of other studies, which 
can be attributed to the nature of fat consumed in the 
diet (as mentioned earlier). Results of the present study 
can be useful for making a metabolic syndrome model for 
both pharmaceutical and pathological studies. We pro-
vide a disease model similar to the disease which exists 
in the society and indicate risk of high fat consumption 
with dairy sources in the society. Thus, it is necessary 
to recommend to people to decrease their consumption 
of high-fat dairies and substitute it with low-fat dairies 
which can nourish them with calcium, protein and nutri-
ents existing in dairy and keep them away from facing 
dairy fat.
Glossary
Metabolic Syndrome (MS) Clustering of at least three of five of the following 
medical conditions: abdominal (central) obesity elevated blood pressure, ele-
vated fasting plasma glucose, high serum triglycerides, and low high-density 
lipoprotein (HDL) levels.
HOMA index The homeostatic model assessment (HOMA) is a method used 
to quantify insulin resistance (HOMA-IR) beta-cell function (HOMA-B) and insu-
lin sensitivity (HOMA-S).
Animal Model Animal Model are in vivo models and are widely used to 
research human disease when human experimentation would be unfeasible 
or unethical.
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